Technical Analysis for ARVN - Arvinas, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 32.33 | 3.09% | 0.97 |
ARVN closed up 3.09 percent on Wednesday, May 15, 2024, on approximately normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 200 DMA Resistance | Bearish | 3.09% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 21 hours ago |
| Up 5% | about 22 hours ago |
| Up 1 ATR | about 22 hours ago |
| Gap Up Partially Closed | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 53.08 |
| 52 Week Low | 13.57 |
| Average Volume | 679,149 |
| 200-Day Moving Average | 31.72 |
| 50-Day Moving Average | 37.62 |
| 20-Day Moving Average | 32.67 |
| 10-Day Moving Average | 32.29 |
| Average True Range | 1.72 |
| RSI (14) | 41.52 |
| ADX | 18.78 |
| +DI | 20.64 |
| -DI | 19.82 |
| Chandelier Exit (Long, 3 ATRs) | 30.71 |
| Chandelier Exit (Short, 3 ATRs) | 36.06 |
| Upper Bollinger Bands | 34.88 |
| Lower Bollinger Band | 30.46 |
| Percent B (%b) | 0.42 |
| BandWidth | 13.53 |
| MACD Line | -1.52 |
| MACD Signal Line | -1.79 |
| MACD Histogram | 0.2711 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 35.18 | ||||
| Resistance 3 (R3) | 35.38 | 34.63 | 34.71 | ||
| Resistance 2 (R2) | 34.63 | 33.90 | 34.53 | 34.55 | |
| Resistance 1 (R1) | 33.48 | 33.46 | 34.06 | 33.28 | 34.39 |
| Pivot Point | 32.73 | 32.73 | 33.02 | 32.63 | 32.73 |
| Support 1 (S1) | 31.58 | 32.00 | 32.16 | 31.38 | 30.27 |
| Support 2 (S2) | 30.83 | 31.56 | 30.73 | 30.11 | |
| Support 3 (S3) | 29.68 | 30.83 | 29.96 | ||
| Support 4 (S4) | 29.48 |
